European Vaccine Markets

Date: November 22, 2010
Pages: 150
Price:
US$ 2,995.00
Publisher: Kalorama Information
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: E1C930BFBC0EN
Leaflet:

Download PDF Leaflet

Sample:

Download Free Sample

European Vaccine Markets
Price (Single User PDF): $2,995.00
Price (Global Site License): $5,990.00


The European vaccines market has demonstrated growth even through tough economic times. This has mainly been due to the introduction of vaccines in untapped disease markets and government’s acceptance and willingness to pay for new products. This has encouraged market participants to increase spending in research and development.


This report, European Vaccine Markets, examines the market for vaccines used in humans to previous various types of disease. It covers only commercialized vaccines and developmental vaccines for diseases that are already vaccine-preventable; it does not cover emerging vaccines for diseases that are not currently vaccine-preventable, such as Alzheimer’s disease, diabetes, Ebola infection, Epstein-Barr virus (EBV) infection, ETEC infection, heart attack, Helicobacter pylori infection, multiple sclerosis, Parkinson’s disease, West Nile virus (WNV) infection, etc.; vaccines that address these conditions are discussed in Kalorama’s new report, “Emerging Vaccines: The World Market.”

The report includes vaccine market stats for:
  • Adult Vaccines-Estimates and Forecasts for
    • Influenza
    • Pneumococcal
    • Meningitis/Pneumonia
    • DTaP
    • Hepatitis
    • HPV
    • Travel and Endemic
    • Others
  • Pediatric Vaccines-Estimates and Forecasts for:
    • Haemophilus influenzae type b (Hib)
    • Pneumococcal infection
    • Diphtheria
    • Tetanus
    • Pertussis (whooping cough)
    • Hepatitis A and B
    • Rotavirus
    • Polio
    • Measles
    • Mumps and Rubella
    • Varicella (chicken pox)
    • Influenza
    • Meningitis
    • Human papillomavirus (HPV)
    • Combination Vaccines
    • Others

The report also contains adult and pediatric vaccine regional market shares for the following countries:
  • United Kingdom
  • Germany
  • Spain
  • France
  • Italy
  • Rest of Europe*

*In this Kalorama Information Report "Rest of Europe" is broken down in the total market summary (adult and pediatric combined) to include regional market share of the total European Vaccine market for Benelux, Scandinavia, Switzerland, Russia, Poland, Balkans, Baltic Countries, Hungary and Other

The report also includes company market shares for European adult and pediatric vaccine markets, key issues and trend affecting the industry, and detailed profiles of major vaccine competitors, including:
  • Bavarian Nordic A/S
  • Baxter International
  • Crucell
  • Emergent Biosolutions
  • GlaxoSmithKline
  • Novartis
  • Pfizer Inc.
  • Sanofi Pasteur
CHAPTER ONE: EXECUTIVE SUMMARY

THE EUROPEAN VACCINES MARKET
Scope and Methodology
Overview
Pediatric Preventative Vaccines
Adult Preventative Vaccines
Total Market
Issues and Trends

CHAPTER TWO: INTRODUCTION TO VACCINES

A Brief History: The Development of Vaccines
The Immune Response
Mechanism of Action
Types of Vaccines
Attenuated (Weakened) Live Viruses
  Killed (Inactivated) Viruses
  Toxoid Vaccines
Genetically Engineered/Modified Vaccines
  Subunit Vaccines
  Conjugate Vaccines
  DNA Vaccination
Vaccine Approval Process

CHAPTER THREE: PEDIATRIC PREVENTIVE VACCINES

Introduction
  United Nations Initiatives
Pediatric Vaccine Products
  BCG
  Diphtheria, Tetanus, Pertussis, Hepatitis B and Polio
  Diphtheria
  Pertussis
  Tetanus
  Hepatitis B
  Poliomyelitis
  Haemophilus Influenzae Type B
  Hepatitis A
  Measles, Mumps and Rubella
  Measles
  Mumps
  Rubella
  Meningococcal Disease
  Pneumococcal Conjugate
  Rotavirus
  Varicella
Pediatric Vaccines in Development
The European Market for Pediatric Preventive Vaccines
Total European Market Size and Forecast
European Market by Product Type
Haemophilus Influenzae Type B (Hib)
Pneumococcal
DTaP
Hepatitis A & B
Rotavirus
Polio
MMR
Varicella
Influenza
Menigococcal
HPV
Combinations
Others
Major Manufacturer’s Market Share—Pediatric Vaccines

CHAPTER FOUR: ADULT PREVENTIVE VACCINES

Introduction
Adult Vaccine-Preventable Diseases: Facts and Figures
Recommendations for Adult Immunization
  WHO International Health Regulations
Adult Vaccine Products
  BCG
  Cervical Cancer
  Cholera
  Diphtheria-Tetanus
  Hepatitis
  Hepatitis A
  Hepatitis B
  Influenza
  Pneumococcal Disease
  Rabies
  Shingles
  Typhoid Fever
Adult Vaccines in Development
The European Market for Adult Preventive Vaccines
  Total European Market Size and Forecast
  European Market by Product Type
  Influenza
  DTaP Booster
  HPV
  Hepatitis
  Meningitis/Pneumonia
  Travel/Endemic Vaccines
  Others
  Major Manufacturer’s Market Share—Adult Vaccines

CHAPTER FIVE: VACCINES MARKET SUMMARY

Trends Driving the Vaccines Market
Market Size and Forecast
Vaccine Sales by Region
Vaccine Market Competitors

CHAPTER SIX: ISSUES AND TRENDS

Vaccine Safety
  Refusal to Immunize
  Obesity
  World Health Organization
  The Future of Vaccine Safety
Vaccine Shortages
  Financial incentives
  Equitable pricing
  Vaccine stockpiles
  Smallpox
  Tularemia
  Viral Hemorrhagic Fevers
DNA Vaccination
Innovations in Vaccine Delivery Systems
  Edible Vaccines
  Mucosal Delivery
  Intranasal Delivery
  Vaccine Patches
  Vaccine Chips
Innovations in Vaccine Production
  Tobacco Plant
  Insects
  Nanoparticle Systems

CHAPTER SEVEN: COMPANY PROFILES

Bavarian Nordic A/S
  History and Lines of Business
  Strategic Alliances
  Vaccine Products
  Financial Information
Baxter International
  History and Lines of Business
  Vaccine Products
  Financial Information
Crucell
  History and Lines of Business
  Strategic Alliances
  Vaccine Products
  Financial Information
Emergent Biosolutions
  History and Lines of Business
  Strategic Acquisition and Alliance
  Vaccine Products
  Financial
GlaxoSmithKline
  History and Lines of Business
  Strategic Alliances
  Vaccine Products
  Financial Information
Novartis
  History and Lines of Business
  Strategic Alliances
  Vaccine Products
  Financial Information
Pfizer Inc.
  History and Lines of Business
  Strategic alliances
  Vaccine Products
  Financial Information
Sanofi Pasteur
  History and Lines of Business
  Strategic Alliances
  Vaccine Products
  Financial Information

COMPANY DIRECTORY
Skip to top


Ask Your Question

European Vaccine Markets
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: